Key Takeaways

  • Issuer: Reckitt Benckiser Treasury Services plc; Guarantor: Reckitt Benckiser Group plc (LSE:RKT).
  • Programme size: GBP 10,000,000,000 Euro Medium Term Note Programme.
  • Tranches launched and priced on 20 May 2026: EUR 650m 3.500% Notes due 28 May 2031; EUR 500m 4.000% Notes due 28 May 2035.
  • Expected Issue Date: 28 May 2026.
  • Final Terms dated 26 May 2026; Base Prospectus dated 29 August 2025, supplemented 15 May 2026.
  • LEI codes: 5493003JFSMOJG48V108 (Reckitt Benckiser Group plc); 213800LAXWIUOOBZ3908 (Reckitt Benckiser Treasury Services plc).

Introduction

Reckitt Benckiser Group plc (LSE:RKT), the FTSE 100 global consumer health and hygiene Business known to many shoppers simply as Reckitt, returned to the London Stock Exchange's Regulatory News Service on 26 May 2026 with an important Debt market update. Released at 17:42:24 with RNS Number 7731F, the EMTN Programme: Publication of Final Terms announcement set out the precise terms of two newly priced tranches of notes to be issued under the group's GBP 10 billion Euro Medium Term Note Programme.

The announcement is a significant regulatory disclosure for fixed income investors, Credit analysts and other Market Participants tracking Reckitt's debt Capital Markets activity. It provides specific information on coupons, sizes, maturities and the wider documentation framework supporting the new issues.

What the Company Announced

Reckitt Benckiser Group plc, together with Reckitt Benckiser Treasury Services plc (the "Issuer"), announced that on 20 May 2026 they successfully launched and priced two tranches of Notes under the Issuer's GBP 10,000,000,000 Euro Medium Term Note Programme.

The first Tranche comprises EUR 650,000,000 3.500 per cent Notes due 28 May 2031. The second tranche comprises EUR 500,000,000 4.000 per cent Notes due 28 May 2035. Together these tranches are referred to in the announcement as the "Notes".

Both tranches are issued by Reckitt Benckiser Treasury Services plc and guaranteed by Reckitt Benckiser Group plc. The Notes are expected to be issued on 28 May 2026.

The Final Terms dated 26 May 2026 relating to the Notes are available for viewing on the Reckitt investor website, and a copy has been submitted to the National Storage Mechanism operated by the Financial Conduct Authority. The Final Terms should be read and construed in conjunction with the Base Prospectus dated 29 August 2025, as supplemented on 15 May 2026.

Key Details from the LSE Announcement

The key contractual and programme details disclosed in the announcement are summarised below:

  • Programme: GBP 10,000,000,000 Euro Medium Term Note Programme of Reckitt Benckiser Treasury Services plc.
  • Issuer: Reckitt Benckiser Treasury Services plc.
  • Guarantor: Reckitt Benckiser Group plc.
  • Date of launch and pricing: 20 May 2026.
  • Tranche 1: EUR 650,000,000 3.500 per cent Notes due 28 May 2031.
  • Tranche 2: EUR 500,000,000 4.000 per cent Notes due 28 May 2035.
  • Expected issue date: 28 May 2026.
  • Final Terms dated: 26 May 2026.
  • Base Prospectus dated 29 August 2025, as supplemented on 15 May 2026.
  • LEI for Reckitt Benckiser Group plc: 5493003JFSMOJG48V108.
  • LEI for Reckitt Benckiser Treasury Services plc: 213800LAXWIUOOBZ3908.
  • Final Terms available via the Reckitt investor website and the FCA's National Storage Mechanism.

Contact points named in the announcement include Nick Ashworth in Investor relations and Catheryn O'Rourke, General Counsel & Company Secretary. The announcement also includes standard selling restrictions, noting that the securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and that the Base Prospectus may not be accessed from or transmitted into the United States.

Why the Announcement Matters

For a large international group like Reckitt, the EMTN programme is a key tool for managing financing across multiple currencies, maturities and structures. By maintaining a GBP 10 billion EMTN programme, the group has the flexibility to access international debt markets in a structured and efficient manner, issuing in tranches as funding needs and market conditions evolve.

The Final Terms publication is the formal disclosure that crystallises the specific economic terms of a particular issue. For the two tranches disclosed on 26 May 2026, the Final Terms identify the precise coupon, Maturity and size of each instrument, as well as confirming the issuer and guarantor relationships, the link to the Base Prospectus and the relevant LEI codes.

For credit investors, the announcement is therefore a focal point. It provides the data needed to evaluate the new notes against the existing curve of Reckitt-related debt, comparable issuers and broader market benchmarks. It also makes clear that the issuance benefits from a Parent Company guarantee from Reckitt Benckiser Group plc.

Company Background

Reckitt Benckiser Group plc is a UK-headquartered consumer health and hygiene group whose portfolio includes a wide range of household brands. According to the announcement, these include Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet. The group describes itself as creating innovative, science-backed solutions intended to help consumers live healthier lives.

As a constituent of the FTSE 100 Index on the London Stock Exchange, Reckitt is widely followed by global investors. The business operates across multiple regions and product categories, with a focus on hygiene, health and nutrition, supported by significant Investment in Research and Development, Brand-building and Supply chain capability.

The company's funding strategy is supported by a debt programme structure that includes the Euro Medium Term Note Programme through Reckitt Benckiser Treasury Services plc, with notes guaranteed by Reckitt Benckiser Group plc. This structure is commonly used by large multinational groups to provide flexibility in accessing debt capital markets.

Market and Sector Context

European Corporate Bond markets in 2026 have continued to evolve in response to changing macro conditions, including the path of interest rates, Inflation dynamics and investor Demand for high-quality issuers. EMTN programmes remain among the principal instruments through which large investment-grade corporates access term debt.

Tranches in the EUR 500 million to EUR 750 million range, with maturities in the 5- to 10-year area, are typical benchmark sizes for large global consumer staples issuers. The 28 May 2031 and 28 May 2035 maturities provide medium- and longer-term funding profiles that can support a balanced debt maturity ladder.

Coupons of 3.500% and 4.000% reflect the prevailing pricing environment for euro-denominated investment-grade corporate debt of comparable tenor at the time of pricing on 20 May 2026. Final pricing for any individual issue depends on a range of factors, including market spreads, issuer-specific credit views and broader risk sentiment.

What It May Mean for Shareholders or Investors

For Reckitt Benckiser Group plc Equity shareholders, the EMTN issuance is a debt market event rather than an equity market event. It does not directly change the share count or the company's operating outlook. However, the transaction is relevant for understanding how the group is funding itself and managing its Capital Structure.

For fixed income investors, the Final Terms publication provides the precise economic terms needed to evaluate the new notes. The notes are issued by Reckitt Benckiser Treasury Services plc and guaranteed by Reckitt Benckiser Group plc, an issuance structure widely used by major UK-listed corporates.

Market participants often view consistent activity under an EMTN programme as evidence of a stable, well-established funding strategy. The latest tranches add new instruments to the issuer's debt curve at clearly defined maturities and coupons, helping support Liquidity and price discovery in the Secondary Market over time.

Risks and Points to Watch

Investors considering Reckitt's EMTN issuance, or following the announcement from a broader market perspective, may keep in mind several considerations:

  • Interest Rate environment: the value of fixed-coupon notes is sensitive to changes in benchmark interest rates.
  • Credit profile: changes in the issuer's or guarantor's credit profile, including any ratings actions, can influence pricing.
  • Currency exposure: the notes are euro-denominated, so currency considerations may be relevant for non-euro investors.
  • Maturity profile: investors should consider how new tranches fit into the issuer's overall debt maturity ladder.
  • Documentation: the Notes are governed by the Final Terms dated 26 May 2026 and the Base Prospectus dated 29 August 2025, as supplemented on 15 May 2026; investors must consult the underlying documentation before making investment decisions.

What Happens Next

The Notes are expected to be issued on 28 May 2026. Once issued, they will sit alongside Reckitt's existing debt obligations and be tradeable in line with their terms. Pricing and liquidity will be subject to normal market dynamics.

Beyond this specific issuance, Reckitt Benckiser Group plc is expected to continue to provide regular financial reporting, including interim and full-year results and trading updates, that will form the principal source of information about the group's operating performance and overall financial position.

Conclusion

Reckitt Benckiser Group plc's 26 May 2026 EMTN Programme: Publication of Final Terms announcement is an important update for fixed income market participants tracking the group's debt issuance. The publication confirms the precise terms of EUR 650 million 3.500% Notes due 28 May 2031 and EUR 500 million 4.000% Notes due 28 May 2035, both issued by Reckitt Benckiser Treasury Services plc and guaranteed by Reckitt Benckiser Group plc.

Together with the existing Base Prospectus dated 29 August 2025, as supplemented on 15 May 2026, the new Final Terms form the basis on which investors can assess the notes. For equity shareholders, the issuance does not directly change the company's operating outlook but adds context to Reckitt's overall capital structure and funding approach.